Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interstitial pneumonia]

Hirofumi Chiba, Shosaku Abe

    Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
    |August 20, 2003
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Smartwatch-Derived SpO<sub>2</sub> Trends During Disease Worsening and Treatment Response in Fibrotic Hypersensitivity Pneumonitis: A Case Report.

    Respirology case reports·2026
    Same author

    A Multicenter Prospective Study on the Safety and Efficacy of the New Low Axial Force Self-Expandable Metallic Stent With Slim Delivery System for Malignant Colorectal Obstruction.

    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society·2026
    Same author

    Afatinib Versus Osimertinib for Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: Real-World Outcomes.

    Cancer science·2026
    Same author

    Pamufetinib (TAS-115) for Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A double-blind, multicenter, phase 2b Clinical Trial.

    American journal of respiratory and critical care medicine·2026
    Same author

    Six-Month Benralizumab Maintenance for Relapsing Chronic Eosinophilic Pneumonia Guided by Eosinophil Kinetics.

    Respirology case reports·2026
    Same author

    Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD).

    ERJ open research·2026